Summary
In order to evaluate the importance of a defect in insulin mediated non-oxidative glucose metabolism and glycogen synthase activity in skeletal muscles in obese subjects with and without Type 2 (non-insulin-dependent) diabetes mellitus we studied: 10 lean and 10 obese control subjects and 12 obese diabetic patients using the euglycaemic hyperinsulinaemic clamp technique (basal, 20 mU · (m2)−1 · min−1, 80mU·(m2)−1·min−1) in combination with indirect calorimetry. Muscle biopsies were taken from m. vastus lateralis at each insulin level. We found that non-oxidative glucose metabolism could be stimulated by insulin in all three groups (p<0.01). The values obtained at the highest insulin levels (around 140 μU/ml) were lower in both obese groups compared to the lean control subjects (118±21, 185±31, 249±14 mg·(m2)−1·min−1 (p< 0.01)). Insulin stimulation of the glycogen synthase activity at a glucose-6-phosphate concentration of 0.1 mmol/l was absent in both obese groups, while activities increased significantly in the lean control subjects (19.6±4.2% to 45.6±6.8%, p< 0.01). Glycogen synthase activities at the highest insulin concentrations only differed significantly between lean control subjects and obese diabetic patients (45±7% and 31±5%, p< 0.05). We conclude that insulin resistance in peripheral tissues in obese subjects with and without Type 2 diabetes may be partly explained by a reduced insulin mediated non-oxidative glucose metabolism and that this abnormality might be due to an absent insulin stimulation of glycogen synthase in skeletal muscles. This enzyme defect is correlated to obesity itself.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Kelley D, Mitrakou A, Marsh H et al. (1988) Skeletal muscle glycolysis, and storage of an oral glucose load. J Clin Invest 88: 1563–1571
DeFronzo RA (1988) The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37: 667–687
Beck-Nielsen H, Hother-Nielsen O (1988) Insulin resistance. Diabetes Ann 4: 565–591
DeFronzo RA, Simonson D, Ferrannini E (1982) Hepatic and peripheral insulin resistance: a common feature of Type 2 (non-insulin-dependent) and Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 23: 313–319
Olefsky JM (1985) Pathogenesis of insulin resistance and hyperglycemia in non-insulin-dependent diabetes mellitus. Am J Med 79 [Suppl 3B]: 1–7
Damsbo P, Hother-Nielsen O, Beck-Nielsen H (1988) Reduced insulin stimulated glucose oxidation in obese Type 2 (non-insulin-dependent) diabetic patients. Diabetologia 31: 483 (Abstract)
Felber JP, Ferrannini E, Golay A et al. (1987) Role of lipid oxidation in pathogenesis of insulin resistance of obesity and Type 2 diabetes. Diabetes 36: 1341–1350
Golay A, DeFronzo RA, Thorin D, Jequier E, Felber JP (1988) Glucose disposal in obese non-diabetic and diabetic Type 2 patients. A study by indirect calorimetry and euglycemic insulin clamp. Diabetes Metab 14: 443–451
Lillioja S, Mott DM, Zawadzki JK, Young AA, Abbot WG, Bogardus C (1986) Glucose storage is a major determinant of in vivo “insulin resistance” in subjects with normal glucose tolerance. J Clin Endocrinol Metab 62: 922–927
Eriksson J, F-Kallunki A, Ekstrand A, Saloranta C, Widen E, Schalin C, Groop L (1989) Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 321: 337–343
Shulman D, Rothman DL, Jue T, Stein P, DeFronzo RA, Shulman RG (1990) Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med 322: 223–228
Mandarino LJ, Wright KS, Verity LS, Nichols J, Bell JM, Kolterman OG, Beck-Nielsen H (1987) Effects of insulin infusion on human skeletal muscle pyruvate dehydrogenase, phosphofructokinase and glycogen synthase. J Clin Invest 80: 655–663
Bogardus C, Lillioja S, Stone K, Mott D (1984) Correlation between muscle glycogen synthase activity and in vivo insulin action in man. J Clin Invest 73: 185–190
Wright KS, Beck-Nielsen H, Kolterman OG, Mandarino LJ (1988) Decreased activation of skeletal muscle glycogen synthase by mixed-meal ingestion in NIDDM. Diabetes 37: 436–440
Kida Y, Puente AE-D, Bogardus C, Mott DM (1990) Insulin resistance is associated with reduced fasting and insulin-stimulated glycogen synthase phosphatase activity in human skeletal muscle. J Clin Invest 85: 476–481
Ferrannini E, Del Prato S, DeFronzo RA (1986) Glucose kinetics. Tracer methods. Methods Diabetes Res 2: 107–141
DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique, a method for quantifying insulin secretion and resistance. Am J Physiol 237: E214–223
Steele R (1959) Influence of glucose loading and of injected insulin on hepatic glucose production. Ann NY Acad Sci 82: 420–430
Tappy L, Owen OE, Boden G (1988) Effect of hyperinsulinemia on urea pool size and substrate oxidation rates. Diabetes 37: 1212–1216
Frayn KN (1983) Calculation of substrate oxidation rates in vivo from gaseous exchange. Am J Physiol 83: 628–634
Hother-Nielsen O, Schmitz O, Bak J, Beck-Nielsen H (1987) Enhanced hepatic insulin sensitivity, but peripheral insulin resistance in patients with Type 1 (insulin-dependent) diabetes. Diabetologia 30: 834–840
Heding LG (1966) A simplified insulin radioimmunoassay method. In: Labelled proteins in tracer studies. European Atomic Energy Community, Brussels, pp 345–350
Heding LG (1975) Radioimmunological determination of human C-peptide in serum. Diabetologia 11: 541–548
DeFronzo RA, Ferrannini E (1982) Influence of plasma glucose and insulin concentrations on plasma glucose clearance in man. Diabetes 31: 683–687
Randle PJ, Garland PB, Hales CN, Newsholme EA (1963) The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet I: 785–789
Freymond D, Bogardus C, Okubo M, Stone K, Mott D (1988) Impaired insulin-stimulated muscle glycogen synthase activation in vivo in man related to low fasting glycogen synthase phosphatase activity. J Clin Invest 82: 1503–1509
Häring H, Obermaier B, Ermel B et al. (1987) Insulin receptor kinase defects as a possible cause of cellular insulin resistance. Diabetes Metab 13: 284–293
Arner P, Pollare T, Lithell H, Livingston JN (1987) Defective insulin receptor tyrosine kinase in human skeletal muscle in obesity and Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 30: 437–440
Caro JF, Sinha MK, Raju SM et al. (1987) Receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. J Clin Invest 79: 1330–1337
Freidenberg GR, Reichart D, Olefsky JM, Henry RR (1988) Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin-dependent diabetes mellitus. J Clin Invest 82: 1398–1406
Evans DJ, Murray R, Kissebah AH (1984) Relationship between skeletal muscle insulin resistance, insulin-mediated glucose disposal, and insulin binding. J Clin Invest 74: 1515–1525
Bogardus C, Lillioja S, Nyomba BL et al. (1989) Distribution of in vivo insulin action in Pima Indians as mixture of three normal distributions. Diabetes 38: 1423–1432
Laws A, Stefanick ML, Reaven GM (1989) Insulin resistance and hypertriglyceridemia in nondiabetic relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 69: 343–347
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Damsbo, P., Vaag, A., Hother-Nielsen, O. et al. Reduced glycogen synthase activity in skeletal muscle from obese patients with and without Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 34, 239–245 (1991). https://doi.org/10.1007/BF00405082
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00405082